Company news

MiMedx Group, Inc news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

MIMEDX to Host Second Quarter 2024 Operating and Financial Results Conference Call on July 31

July 16, 2024

MIMEDX Announces the Appointment of Kim Moller to Chief Commercial Officer

June 25, 2024

MIMEDX Announces First Quarter 2024 Operating and Financial Results

April 29, 2024

MIMEDX to Host First Quarter 2024 Operating and Financial Results Conference Call on April 30

April 15, 2024

MIMEDX Provides Update on AXIOFILL® Request for Designation (“RFD”) from FDA

March 26, 2024

MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing

March 19, 2024

MIMEDX Introduces E-Commerce and Account Management Platform

March 12, 2024

MIMEDX Announces Appointment of Two New Independent Directors

March 3, 2024

MIMEDX Announces Fourth Quarter and Full Year 2023 Operating and Financial Results

February 27, 2024

MIMEDX to Present at TD Cowen 44th Annual Health Care Conference

February 19, 2024

MIMEDX to Host Fourth Quarter and Full Year 2023 Operating and Financial Results Conference Call on February 28

February 11, 2024

MIMEDX Announces Improved Capital Structure with New Senior Secured Credit Facilities and Debt Refinancing

January 21, 2024

MIMEDX Provides AXIOFILL® Update & Reiterates 2023 Full Year Net Sales and Fourth Quarter Adjusted EBITDA Margin Outlook

December 28, 2023

MIMEDX Announces Conversion of Outstanding Series B Convertible Preferred Stock to Common Stock

December 27, 2023

MIMEDX to Highlight Published Data at SAWC Fall

November 1, 2023

MIMEDX Announces Third Quarter 2023 Operating and Financial Results

October 29, 2023

MIMEDX to Host Third Quarter 2023 Operating and Financial Results Conference Call on October 30

October 15, 2023

MIMEDX Announces Launch of EPIEFFECT™

September 25, 2023

MIMEDX to Present at Upcoming Investor Conferences

September 4, 2023

MIMEDX Announces Second Quarter 2023 Operating and Financial Results

July 31, 2023

MIMEDX to Host Second Quarter 2023 Operating and Financial Results Conference Call on August 1

July 17, 2023

MIMEDX Announces Favorable Ruling in Putative Securities Class Action Case

July 10, 2023

MIMEDX Appoints Doug Rice as Chief Financial Officer

July 4, 2023

MIMEDX Announces Strategic Realignment: Increases Focus on Wound & Surgical Business, Expected to Significantly Improve Profitability

June 19, 2023

MIMEDX Announces First Quarter 2023 Operating and Financial Results

May 1, 2023

MIMEDX to Host First Quarter 2023 Operating and Financial Results Conference Call on May 2

April 17, 2023

MIMEDX Announces Chief Financial Officer Transition

March 22, 2023

MIMEDX Comments on Recent Data Brief Published by Office of Inspector General

March 15, 2023

MIMEDX Announces Fourth Quarter and Full Year 2022 Operating and Financial Results

February 27, 2023

MIMEDX to Host Fourth Quarter and Full Year 2022 Operating and Financial Results Conference Call on February 28

February 14, 2023

MIMEDX Appoints Joseph H. Capper as Chief Executive Officer and Director

January 29, 2023

MIMEDX Confirms Fourth Quarter and Full Year 2022 Net Sales Expectations, Comments on Evolving Medicare Reimbursement Landscape and Provides Corporate Updates

January 8, 2023

MIMEDX Announces Commercial Launch of EPIFIX® in Japan with Exclusive Distribution Agreement with GUNZE MEDICAL LIMITED

January 3, 2023

MIMEDX Appoints Ricci S. Whitlow as Chief Operating Officer

January 2, 2023

MIMEDX Announces Wound & Surgical Product Pipeline Expansion via In-Licensing and Distribution Agreement with Turn Therapeutics

December 7, 2022

MIMEDX Announces Third Quarter 2022 Operating and Financial Results

November 1, 2022

MIMEDX to Host Third Quarter 2022 Operating and Financial Results Conference Call on November 2

October 18, 2022

MIMEDX Appoints Matt Notarianni as Head of Investor Relations

October 3, 2022

MIMEDX Announces Launch of AXIOFILL™

September 19, 2022

MIMEDX Announces Launch of AMNIOEFFECT™

September 18, 2022

MIMEDX EPIFIX® Receives Reimbursement Approval in Japan

September 11, 2022

MIMEDX Announces Leadership Transition

September 5, 2022

MIMEDX to Present at the Canaccord Genuity 42nd Annual Growth Conference

August 3, 2022

MIMEDX Announces Second Quarter 2022 Operating and Financial Results

August 1, 2022

MIMEDX Announces Formation of Regenerative Medicine Scientific Advisory Board Comprised of Renowned Industry and Academic Experts

July 26, 2022

MIMEDX to Host Second Quarter 2022 Operating and Financial Results Conference Call on August 3

July 19, 2022

MIMEDX Welcomes Kate Surdez as Chief Human Resources Officer

July 17, 2022

MIMEDX Engages Nordic Bioscience Clinical Development A/S to Propel Registrational Trials of Placental Biologic Injectable for Knee Osteoarthritis

June 14, 2022

MIMEDX Shareholders Vote to Approve All Proposals at the 2022 Annual Meeting

June 6, 2022

MIMEDX Reminds Shareholders to Pre-Register for the Upcoming Virtual 2022 Annual Meeting of Shareholders

June 2, 2022

← Newer news releases · Older news releases →

Calls

The 5 newest of 24 calls. Every call is listed under its year.

Decks

The 5 newest of 62 decks. Every deck is listed under its year.